Optimize Pricing & Reimbursement
Streamline pricing and reimbursement in a complex pharma contracting world
As the complexity of investments needed to secure patient access to therapy increases, so does the impact of these investments on a company’s net revenue.
EVERSANA offers a comprehensive solution set that spans the entire product lifecycle, helping clients enhance, optimize and integrate the steps necessary to maximize access and value.
Optimal pricing and reimbursement is achieved with Comprehensive Products and Services, including:
-
Market Assessment & Insights
NAVLIN Insights delivers the intelligence you need to validate or inform your strategy across the product life cycle.
Learn More -
Global Pricing Data & Software
NAVLIN by EVERSANA includes proprietary price & access data and software platforms to help you assess your pricing and launch strategies globally. Answer the complex questions impacting your revenue.
Learn More -
Market Access Strategy & Stakeholder Engagement
Breaking down the complexity of reimbursement and access. Engaging the Patient, Payer and Provider.
Learn More -
Global Channel & 3PL
Distribution from Day 1 including special logistics for regenerative medicine and cash flow management.
Learn More -
Revenue Management
Reduce revenue leakage, implement innovative contracting strategies, optimize your revenue across the product life cycle.
Learn More
Client Success Stories
-
Research, Data and Technology Create Market Access Solutions
Primary Research Meets Data-Driven Sources and Technology to Form Powerful Market Access Solutions
GET THE CASE STUDY -
Pricing Strategy Matters
Holistic view of pricing maximizes revenue for a pharmaceutical manufacturer
DOWNLOAD
“Keeping up with the Reference Pricing Landscape”
Webinar presented by Alan Crowther, Global Pricing Team
Worldwide, pricing policy is always in flux. In this webinar, EVERSANA’s General Manager of Global Pricing and Access, Alan Crowther, examines global trends impacting the International Reference Pricing (IRP) landscape and discusses the possible effects these could have on the United States’ proposed International Pricing Index (IPI). In this discussion, Crowther looks beyond the in-country impact to what the external impact or spillover could be in each scenario.
